Skip to content

Omnicell OMCL Finished goods

Finished goods at other companies

ICU Medical logo
ICU MedicalICUI
$289.36M+9.9%
Haemonetics logo
HaemoneticsHAE
$189.37M-16.0%
Solventum logo
SolventumSOLV
$643M+32.9%
GHC
Graham HoldingsGHC
$208.34M+2.0%
Baxter International logo
Baxter InternationalBAX
Medline, Inc.
 logo
Medline, Inc. MDLN

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.8B-7.2%
Enterprise value$1.54B-0.4%
P/E116.4×
P/S1.5×-0.2×

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's finished goods?
Omnicell (OMCL) reported finished goods of $71.01M in Q1 2026.
How has Omnicell's finished goods changed year-over-year?
Omnicell's finished goods increased by 30.4% year-over-year, from $54.47M to $71.01M.
What is the long-term trend for Omnicell's finished goods?
Over 5 years (2020 to 2025), Omnicell's finished goods has grown at a 4.1% compound annual growth rate (CAGR), from $60.12M to $73.34M.
What does finished goods mean?
Completed products ready for sale, valued at the lower of cost or net realizable value.